Yin M - Search Results

1

Chk2*1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in mice.

Meyer SE, Peace BE, Bahassi el M, Kavanaugh GM, Wagh PK, Robbins SB, Yin M, Wells SI, Zinser GM, Stambrook PJ, Waltz SE. Meyer SE, et al. Among authors: yin m. Cancer Lett. 2010 Oct 28;296(2):186-93. doi: 10.1016/j.canlet.2010.04.011. Cancer Lett. 2010. PMID: 20434834 Free PMC article.

2

The breast cancer susceptibility allele CHEK2*1100delC promotes genomic instability in a knock-in mouse model.

Bahassi el M, Penner CG, Robbins SB, Tichy E, Feliciano E, Yin M, Liang L, Deng L, Tischfield JA, Stambrook PJ. Bahassi el M, et al. Among authors: yin m. Mutat Res. 2007 Mar 1;616(1-2):201-9. doi: 10.1016/j.mrfmmm.2006.11.025. Epub 2006 Dec 15. Mutat Res. 2007. PMID: 17174984

3

Mice with the CHEK2*1100delC SNP are predisposed to cancer with a strong gender bias.

Bahassi el M, Robbins SB, Yin M, Boivin GP, Kuiper R, van Steeg H, Stambrook PJ. Bahassi el M, et al. Among authors: yin m. Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17111-6. doi: 10.1073/pnas.0909237106. Epub 2009 Sep 21. Proc Natl Acad Sci U S A. 2009. PMID: 19805189 Free PMC article.

4

Absence of polo-like kinase 3 in mice stabilizes Cdc25A after DNA damage but is not sufficient to produce tumors.

Myer DL, Robbins SB, Yin M, Boivin GP, Liu Y, Greis KD, Bahassi el M, Stambrook PJ. Myer DL, et al. Among authors: yin m. Mutat Res. 2011 Sep 1;714(1-2):1-10. doi: 10.1016/j.mrfmmm.2011.02.006. Epub 2011 Mar 3. Mutat Res. 2011. PMID: 21376736 Free PMC article.

5

A human cancer-predisposing polymorphism in Cdc25A is embryonic lethal in the mouse and promotes ASK-1 mediated apoptosis.

Bahassi el M, Yin M, Robbins SB, Li YQ, Conrady DG, Yuan Z, Kovall RA, Herr AB, Stambrook PJ. Bahassi el M, et al. Among authors: yin m. Cell Div. 2011 Feb 10;6(1):4. doi: 10.1186/1747-1028-6-4. Cell Div. 2011. PMID: 21310058 Free PMC article.

6

Acetylation and deacetylation of Cdc25A constitutes a novel mechanism for modulating Cdc25A functions with implications for cancer.

Lozada EM, Andrysik Z, Yin M, Redilla N, Rice K, Stambrook PJ. Lozada EM, et al. Among authors: yin m. Oncotarget. 2016 Apr 12;7(15):20425-39. doi: 10.18632/oncotarget.7966. Oncotarget. 2016. PMID: 26967250 Free PMC article.

7

Loss of heterozygosity and point mutation at Aprt locus in T cells and fibroblasts of Pms2-/- mice.

Shao C, Yin M, Deng L, Stambrook PJ, Doetschman T, Tischfield JA. Shao C, et al. Among authors: yin m. Oncogene. 2002 Apr 25;21(18):2840-5. doi: 10.1038/sj.onc.1205358. Oncogene. 2002. PMID: 11973643

8

Transforming growth factor beta1 enhances platelet aggregation through a non-transcriptional effect on the fibrinogen receptor.

Hoying JB, Yin M, Diebold R, Ormsby I, Becker A, Doetschman T. Hoying JB, et al. Among authors: yin m. J Biol Chem. 1999 Oct 22;274(43):31008-13. doi: 10.1074/jbc.274.43.31008. J Biol Chem. 1999. PMID: 10521498 Free article.

9

Expression and loss of alleles in cultured mouse embryonic fibroblasts and stem cells carrying allelic fluorescent protein genes.

Larson JS, Yin M, Fischer JM, Stringer SL, Stringer JR. Larson JS, et al. Among authors: yin m. BMC Mol Biol. 2006 Oct 16;7:36. doi: 10.1186/1471-2199-7-36. BMC Mol Biol. 2006. PMID: 17042952 Free PMC article.

10

Role of Transforming Growth Factor 1 in Lymphocyte Development and Death.

Bommireddy R, Ormsby I, Yin M, Doetschman TC. Bommireddy R, et al. Among authors: yin m. ScientificWorldJournal. 2001 Nov 9;1:146. doi: 10.1100/tsw.2001.243. eCollection 2001. ScientificWorldJournal. 2001. PMID: 30147623 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,985 results

Search Page

Filters